AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
By B. Shea, Barnaby C. Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, D. Moher, P. Tugwell, Vivian Welch, E. Kristjansson and 1 more. British medical journal, 2017
9,335 citations recorded by the source corpus.
The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.
Subfields: Economics and Econometrics, Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/d926f7ad7cc14b4ec56b04b27138ffbb7131f10d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- David Moher
- I. Boutron
- Matthew J. Page
- Larissa Shamseer
- Patrick M. M. Bossuyt
- J. Tetzlaff
- C. Mulrow
- Jeremy M. Grimshaw
In Sociology and Political Science
- Matthew J. Page
- David Moher
- Terri D. Pigott
- Catherine H. Fowler
- J. Yepes‐Nuñez
- Marta Romero-García
- G. Úrrutia
- S. Alonso-Fernández
In Statistics and Probability
- David Moher
- Matthew J. Page
- Larissa Shamseer
- I. Boutron
- J. Polanin
- J. Yepes‐Nuñez
- G. Úrrutia
- Marta Romero-García
Citations in the corpus
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (2021, methodology): “PRISMA 2020 should not be used to assess the conduct or methodological quality of systematic reviews; other tools exist for this purpose [30 , 31] .”
- Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews (2023, background): “29”
- Canadian 24-Hour Movement Guidelines for Adults aged 18-64 years and Adults aged 65 years or older: an integration of physical activity, sedentary behaviour, and sleep. (2020, methodology): “For the overview of reviews, the quality of the evidence was extracted and reported as evaluated by the systematic review authors, and the quality of the systematic reviews themselves was assessed using the A MeaSurement Tool to Assess systematic Reviews II (AMSTAR II) criteria (Shea et al. 2017).”
- SANRA—a scale for the quality assessment of narrative review articles (2019, background): “Critical appraisal tools have been developed for systematic reviews (e.g., AMSTAR 2 [A MeaSurement Tool to Assess Systematic Reviews] [7]) and papers on RCTs (e.g., the CASP [Critical Appraisal Skills Program] checklist for randomized trials [8]) and other types of medical studies.”
- Effects of aromatherapy on sleep quality in patients: Protocol for an umbrella review (2025, neutral): “Methodological quality will be independently evaluated by two reviewers using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR 2) tool [20].”
- A step by step guide for conducting a systematic review and meta-analysis with simulation data (2019, methodology): “According to the AMSTAR guidelines, at least two databases have to be searched in the SR/MA [8], but as you increase the number of searched databases, you get much yield and more accurate and comprehensive results.”
- Methodological Guidance Paper: High-Quality Meta-Analysis in a Systematic Review (2019, methodology): “Our recommendations are consistent with guidelines for reporting metaanalysis from many fields (Appelbaum et al., 2018; Centre for Reviews and Dissemination, 2009; Higgins & Green, 2011; Institute of Medicine, 2011; Moher et al., 2009; Shea et al., 2017).”
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. (2020, methodology): “Systematic reviews and meta-analyses were assessed for quality using the AMSTAR tool.(12) Design elements such as blinding, allocation concealment, sufficient sample size, intention to treat, and funding sources were assessed for RCTs.”
- Updating the Secondary Transition Research Base: Evidence- and Research-Based Practices in Functional Skills (2020, methodology): “We followed guidelines presented by Shea et al. (2017) to ensure the methodological rigor of this systematic literature review.”
- Barriers and facilitators to utilizing digital health technologies by healthcare professionals (2023, methodology): “Data extraction and quality assessment Two independent researchers appraised the methodological quality of included systematic reviews using the AMSTAR-2 tool 154 .”
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021, methodology): “[28,29] Evidence on sources of bias in systematic reviews has accrued, culminating in the development of new tools to appraise the conduct of systematic reviews.[30, 31] Terminology used to describe particular review processes has also evolved, as in the shift from assessing “quality” to assessing “”